PMA supplement

P130017 S033: Cologuard

FDA PMA supplement · 30-Day Notice · Exact Sciences Corporation

Key facts

Original PMA P130017
Supplement number S033
Supplement type 30-Day Notice
Reason for the supplement Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name Cologuard
Generic name System, colorectal neoplasia, DNA methylation and hemoglobin detection
Applicant Exact Sciences Corporation
Product code PHP
Received date Sep 18, 2019
Decision date Oct 18, 2019

At a glance

  • No Expedited review granted
  • No Approval order on file
  • No Summary of safety and effectiveness on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA supplements

A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA supplements